ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2373

The Clinical Course of the Acute Deep Vein Thrombosis of the Legs in Behçet’s Syndrome

Yesim Ozguler1, Melike Melikoglu2, Firat Cetinkaya3, Serdal Ugurlu4, Emire Seyahi5, Koray Tascilar6 and Hasan Yazici7, 1Cerrahpasa Medical Faculty, Istanbul University, Cerrahpasa Medical School, Rheumatology, Istanbul, Turkey, 2Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey, 3Radiology, Colormed Radiology Center, Istanbul, Turkey, 4Rheumatology, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey, 5Rheumatology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey, 6University of Istanbul, Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey, 7Istanbul University, Cerrahpasa Medical School, Rheumatology, Istanbul, Turkey

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose: 15-50% of patients with Behçet’s syndrome have vascular involvement (BS). Deep vein thrombosis is the most common form with lower extremity deep vein thrombosis (LEDVT) making up 70% of all vascular involvement. The aim of this study was to determine the clinical course of LEDVT about which there has been little data.

Methods: Consecutive BS patients attending our multidisciplinary BS outpatient clinic were included after an acute or subacute first episode of LEDVT in one leg. They might have had a previous episode of LEDVT in the contralateral extremity. The same radiologist performed a structured and detailed lower extremity Doppler ultrasonography (US). All deep veins, VCI and major superficial veins were examined at 1, 3, 6, 18 and 24 months after the index event. Nodular lesions that evolved during the follow-up were also examined for their US structure to differentiate between the presence of superficial vein thrombosis and erythema nodosum.

Results:

Within a course of 20 months 31 patients (4F, 27M) with LEDVT in a previously uninvolved leg were seen and included in the study. 10 patients had had a previous episode of LEDVT in the opposite leg. Mean age was 29.5 ± 7, mean disease duration since disease onset was 49.5± 34.6, and the mean follow-up duration during the study was 13.4 ± 6.2 months. Veins involved in order of frequency were popliteal vein (42%), superficial femoral vein (31%), crural veins (29%) and common femoral vein (27%). VCI was involved in 3 (5%) patients. 14 patients (45%) relapsed during follow-up. 11 patients relapsed with a superficial thrombophlebitis and 5 patients relapsed with a new deep vein thrombosis. Mean time to relapse was 2.83 ± 1.99 months when the relapse was a superficial thrombophlebitis and 6.0 ± 2.3 months when the relapse was a LEDVT (P=0.001). Only 3 out of 19 patients who had a recanalization (≥50%) at month 3 follow-up had a relapse. On the other hand, a relapse was observed in 11 of the 12 patients with poor recanalization (<50%) (P=0.001). All 3 patients with VCI involvement had venous skin ulcers in the lower extremity and these 3 patients were also the only patients with skin ulcers in the whole group. 17/31 (55%) patients developed nodular lesions during the study. 13/17 had had previous episodes of nodular lesions while in 4 patients these appeared for the first time. Doppler ultrasonographic examination of these nodules revealed superficial thrombophlebitis in 12 (70%) and like lesions in 5 patients (29%).

Conclusion: The more common vascular relapse after an episode of LEDVT is superficial thrombophlebitis. Relapses of a superficial thrombophlebitis occur earlier than relapses with a LEDVT. Poor recanalization of the index LEDVT at 3 months is associated with relapses. The presence of skin ulcers seems to go along with inferior vena caval thrombosis. As expected, LEDVT in BS is associated more with superficial thrombophlebitis than with erythema nodosum lesions.


Disclosure:

Y. Ozguler,
None;

M. Melikoglu,
None;

F. Cetinkaya,
None;

S. Ugurlu,
None;

E. Seyahi,
None;

K. Tascilar,
None;

H. Yazici,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-clinical-course-of-the-acute-deep-vein-thrombosis-of-the-legs-in-behcets-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology